Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians’ Perspective in a Real-World Setting, Insight from a Web Survey
Crossref DOI link: https://doi.org/10.1007/s13300-018-0476-3
Published Online: 2018-07-30
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Imai, Kota
Murayama, Hiroki
Hirose, Takahisa
Funding for this research was provided by:
Novartis Pharma kk
Article History
Received: 22 June 2018
First Online: 30 July 2018